Bangladesh bans heartburn drug ranitidine over cancer fears
Bangladesh’s drug regulatory authority on Sunday issued a ban on sales of popular heartburn drug ranitidine while it investigates a potential cancer-causing substance in the drug.
Related articles
-
Vision for Cumberland's performing arts center takes shape
November 19, 2018 -
Clemson, Bama top updated national title odds
September 11, 2020
